Evidence map›Paper›PMID 26905525›Full record

ArticleScientific reports2016

Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.

Lisa Pasterk, Sandra Lemesch, Bettina Leber, Markus Trieb, Sanja Curcic, Vanessa Stadlbauer, Rufina Schuligoi, Rudolf Schicho, Akos Heinemann, Gunther Marsche

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Antioxidants (Basel, Switzerland) · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Secretory phospholipase AScientific reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lisa PasterkInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Sandra LemeschDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria.
Bettina LeberDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria.
Markus TriebInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Sanja CurcicInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Vanessa StadlbauerDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria.
Rufina SchuligoiInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Rudolf SchichoInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Akos HeinemannInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Gunther MarscheInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Medical University of Graz · AT

Funding

Austrian Science Fund FWF P 25633Austrian Science Fund FWF P 26185
6 · The paper itself

Abstract

Plasma advanced oxidation protein products (AOPPs), a class of pro-inflammatory pathogenic mediators, accumulate in subjects with chronic kidney disease. Whether AOPPs contribute to coagulation abnormalities, which are frequently seen in uremic patients, is unknown. Here we report that AOPPs activate platelets via a CD36-mediated signaling pathway. Activation of signaling pathways by AOPP-platelet interaction resulted in the expression of several platelet activation markers and rapidly induced the expression of CD40 ligand, triggering platelet adhesion to endothelial cells and promoting endothelial tissue factor expression. AOPPs and serum tissue factor levels were considerably increased in end stage renal disease patients on hemodialysis and a significant correlation of AOPPs and serum tissue factor was found. Interestingly, serum levels of AOPPs and tissue factor were substantially lower in stable kidney transplant patients when compared with hemodialysis patients. Given that CD36 is known to transduce the effects of oxidized lipids into platelet hyperactivity, our findings reveal previously unknown pro-thrombotic activities of oxidized plasma albumin via a CD36 dependent pathway.

Indexed as

AdolescentAdultAdvanced Oxidation Protein ProductsAgedAged, 80 and overBlood PlateletsCD36 AntigensCD40 LigandEndothelial CellsFemaleGene Expression RegulationHumansKidney Failure, ChronicKidney TransplantationMaleMiddle AgedAdvanced Oxidation Protein ProductsCD36 AntigensCD40 LigandSerum AlbuminThromboplastin

Identifiers

PMID26905525
PMCPMC4764952
OpenAlexW2416949617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.